The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia
Introduction: Negative symptoms, neurocognitive deficits and functional impairment are prevalent in individuals with major depressive disorder (MDD) and schizophrenia (SCZ). However, unlike neurocognitive deficits, little is known about the role of negative symptoms toward functioning in individuals...
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/154080 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-154080 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1540802022-06-08T05:53:24Z The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia Quek, Yue Feng Yang, Zixu Dauwels, Justin Lee, Jimmy Lee Kong Chian School of Medicine (LKCMedicine) School of Electrical and Electronic Engineering Institute of Mental Health Science::Medicine Major Depressive Disorder Schizophrenia Introduction: Negative symptoms, neurocognitive deficits and functional impairment are prevalent in individuals with major depressive disorder (MDD) and schizophrenia (SCZ). However, unlike neurocognitive deficits, little is known about the role of negative symptoms toward functioning in individuals with MDD. On the other hand, both factors are well-studied in individuals with SCZ. Thus, this study aimed to examine the contributions of negative symptoms and neurocognitive impairments in functioning in individuals with MDD, compared to individuals with SCZ. Methods: Participants included 50 individuals with MDD, 49 individuals with SCZ and 49 healthy controls. The following measures were administered-Negative Symptom Assessment (NSA-16), Brief Assessment of Cognition in Schizophrenia (BACS), Patient Health Questionnaire (PHQ-9), and MIRECC-Global Assessment of Functioning (MIRECC-GAF) to evaluate negative symptoms, neurocognition, depressive symptoms, and functioning respectively. Results: Both MDD and SCZ groups had significantly more severe negative symptoms, depressive symptoms, and poorer functioning than healthy controls. Individuals with SCZ performed significantly poorer on the BACS than the other two groups. Both negative symptoms and neurocognition were significantly correlated with social and occupational functioning in SCZ. Motivation subdomain of the negative symptoms was significantly correlated with occupational functioning, while depressive symptoms correlated with functioning in MDD. Conclusion: Both negative symptoms and neurocognitive deficits appear to play differential roles on individual domains of functioning between MDD and SCZ. Future longitudinal studies with larger sample sizes should be done for a better understanding about the associations between the factors and functioning. Published version This study was funded by Rehabilitation Research Institute of Singapore (RRIS) (Psychosocial Rehabilitation & Quality of Life (QoL)/RRG2-16009). 2022-06-08T05:53:24Z 2022-06-08T05:53:24Z 2021 Journal Article Quek, Y. F., Yang, Z., Dauwels, J. & Lee, J. (2021). The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia. Frontiers in Psychiatry, 12, 648108-. https://dx.doi.org/10.3389/fpsyt.2021.648108 1664-0640 https://hdl.handle.net/10356/154080 10.3389/fpsyt.2021.648108 34381384 2-s2.0-85112650262 12 648108 en QoL/RRG2-16009 Frontiers in Psychiatry © 2021 Quek, Yang, Dauwels and Lee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Science::Medicine Major Depressive Disorder Schizophrenia |
spellingShingle |
Science::Medicine Major Depressive Disorder Schizophrenia Quek, Yue Feng Yang, Zixu Dauwels, Justin Lee, Jimmy The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia |
description |
Introduction: Negative symptoms, neurocognitive deficits and functional impairment are prevalent in individuals with major depressive disorder (MDD) and schizophrenia (SCZ). However, unlike neurocognitive deficits, little is known about the role of negative symptoms toward functioning in individuals with MDD. On the other hand, both factors are well-studied in individuals with SCZ. Thus, this study aimed to examine the contributions of negative symptoms and neurocognitive impairments in functioning in individuals with MDD, compared to individuals with SCZ. Methods: Participants included 50 individuals with MDD, 49 individuals with SCZ and 49 healthy controls. The following measures were administered-Negative Symptom Assessment (NSA-16), Brief Assessment of Cognition in Schizophrenia (BACS), Patient Health Questionnaire (PHQ-9), and MIRECC-Global Assessment of Functioning (MIRECC-GAF) to evaluate negative symptoms, neurocognition, depressive symptoms, and functioning respectively. Results: Both MDD and SCZ groups had significantly more severe negative symptoms, depressive symptoms, and poorer functioning than healthy controls. Individuals with SCZ performed significantly poorer on the BACS than the other two groups. Both negative symptoms and neurocognition were significantly correlated with social and occupational functioning in SCZ. Motivation subdomain of the negative symptoms was significantly correlated with occupational functioning, while depressive symptoms correlated with functioning in MDD. Conclusion: Both negative symptoms and neurocognitive deficits appear to play differential roles on individual domains of functioning between MDD and SCZ. Future longitudinal studies with larger sample sizes should be done for a better understanding about the associations between the factors and functioning. |
author2 |
Lee Kong Chian School of Medicine (LKCMedicine) |
author_facet |
Lee Kong Chian School of Medicine (LKCMedicine) Quek, Yue Feng Yang, Zixu Dauwels, Justin Lee, Jimmy |
format |
Article |
author |
Quek, Yue Feng Yang, Zixu Dauwels, Justin Lee, Jimmy |
author_sort |
Quek, Yue Feng |
title |
The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia |
title_short |
The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia |
title_full |
The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia |
title_fullStr |
The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia |
title_full_unstemmed |
The impact of negative symptoms and neurocognition on functioning in MDD and schizophrenia |
title_sort |
impact of negative symptoms and neurocognition on functioning in mdd and schizophrenia |
publishDate |
2022 |
url |
https://hdl.handle.net/10356/154080 |
_version_ |
1735491198270832640 |